Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM | NASDAQ
Chart Builder DCF Calculator
$25.26
+$0.31 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$25.35
+$0.09 (+0.37%)
Pre-market: Sep 22, 2026, 5:44 AM ET

Market Data

Market Cap
$2.57B
Enterprise Value
$1.69B
Beta
2.23
Average Volume
2.05M
Shares Outstanding (Diluted)
104.33M
Shares Change YoY
2.29%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US07373V1052

Price Performance

Price Change 1M
-13.5%
Price Change 3M
-23.9%
Price Change 6M
9.3%
Price Change YTD
-6.9%
Price Change 1Y
3.5%
Price Change 3Y
6.3%
Price Change 5Y
-73.3%
1M CAGR (ann.)
-8.4%
1Y CAGR (ann.)
11.1%
5Y CAGR (ann.)
-25.5%
All-Time CAGR
4.4%

Valuation

PE Ratio
-29.37
Forward PE
N/A
PEG Ratio
-0.41
Forward PEG
-3.82
PS Ratio
16.65
Forward PS
40.70
PB Ratio
2.43
P/FCF Ratio
-6.97
P/Adj. FCF Ratio
-7.22
P/OCF Ratio
-7.34
EV/Sales
10.85
EV/EBIT
-20.51
EV/EBITDA
-28.08
EV/FCF
-4.54
Earnings Yield
-3.4%
FCF Yield
-14.3%
Adj. FCF Yield
-13.8%

Financial Health

Net Cash
$1.05B
Total Debt
$247.36M
Cash & Short-Term Investments
$1.15B
Total Assets
$1.39B
Current Ratio
14.57
Quick Ratio
14.57
Debt / Equity Ratio
0.23
Debt / EBITDA
-4.10
Debt / FCF
-0.66
OCF / Debt
-1.45
Interest Coverage
-35.53
Altman Z-Score
3.81
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
18.9%
Operating Profit Margin
-242.3%
EBITDA Margin
-38.6%
Net Profit Margin
-54.8%
FCF Margin
-238.9%
Adj. FCF Margin
-230.7%
SBC / Revenue
-8.2%
SBC Impact (per share)
-3.4%

Returns

Return on Assets
-6.2%
Return on Equity
-7.7%
Return on Invested Capital
-28.6%
Return on Capital Employed
-29.0%
Return on Tangible Assets
-6.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
24.9%
Revenue CAGR 5Y
478.9%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
19.9%
EPS CAGR 5Y
13.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-37.3%
FCF CAGR 5Y
-42.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
27
EPS Growth Next 3Y
-95.1%
Revenue Growth Next 3Y
27.7%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$59.50
Price Target Upside
135.6%

Cash Flow

Operating Cash Flow
$-359.38M
Free Cash Flow
$-372.77M
Adj. Free Cash Flow
$-360.04M
FCF Per Share
-$3.57
OCF Per Share
-$3.44
OCF/S Ratio
-230.3%

Income Statement

Revenue
$156.04M
Gross Profit
$29.54M
Operating Income
$-378.02M
EBITDA
$-60.29M
Net Income
$-85.43M
EPS (Diluted)
-$0.86
Revenue / Employee
$288.95K
Profit / Employee
$-158.2K
Employees
540

© 2026 bestshares.com. All rights reserved.